30,927 Shares of First Trust Nasdaq Pharmaceuticals ETF $FTXH Acquired by Trust Co. of Oklahoma

Trust Co. of Oklahoma purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 30,927 shares of the company’s stock, valued at approximately $1,283,000. Trust Co. of Oklahoma owned 0.12% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of FTXH. MinichMacGregor Wealth Management LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter valued at $968,000. Compass Financial Management LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth $29,000. Nilsine Partners LLC boosted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock worth $1,071,000 after acquiring an additional 937 shares during the period. Finally, Vivaldi Capital Management LP grew its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after purchasing an additional 1,741 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 2.3%

Shares of NASDAQ FTXH traded up $0.94 during mid-day trading on Thursday, hitting $42.23. The company had a trading volume of 31,859 shares, compared to its average volume of 232,468. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $28.85 and a 1 year high of $43.52. The stock’s 50-day moving average price is $41.11 and its 200-day moving average price is $37.75.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Thursday, September 24th were paid a $0.0113 dividend. The ex-dividend date was Thursday, September 24th. This represents a $0.05 annualized dividend and a yield of 0.1%. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.